PSS20 COST-UTILITY ANALYSIS OF A PRN (AS NEEDED) TREATMENT SCHEDULE WITH RANIBIZUMAB (LUCENTIS) IN WET AMD BASED ON CLINICAL EVIDENCE
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72649-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)72649-3/fulltext
Title :
PSS20 COST-UTILITY ANALYSIS OF A PRN (AS NEEDED) TREATMENT SCHEDULE WITH RANIBIZUMAB (LUCENTIS) IN WET AMD BASED ON CLINICAL EVIDENCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72649-3&doi=10.1016/S1098-3015(11)72649-3
First page :
A401
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
807